Medpace Free Cash Flow Per Share from 2010 to 2024

MEDP Stock  USD 397.56  9.59  2.36%   
Medpace Holdings Free Cash Flow Per Share yearly trend continues to be relatively stable with very little volatility. Free Cash Flow Per Share is likely to grow to 13.56 this year. Free Cash Flow Per Share is the amount of cash Medpace Holdings generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share. View All Fundamentals
 
Free Cash Flow Per Share  
First Reported
2010-12-31
Previous Quarter
12.9134171
Current Value
13.56
Quarterly Volatility
4.10252549
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Medpace Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medpace main balance sheet or income statement drivers, such as Depreciation And Amortization of 28.5 M, Interest Expense of 463.6 K or Total Revenue of 2 B, as well as many exotic indicators such as Price To Sales Ratio of 3.3, Dividend Yield of 0.0011 or PTB Ratio of 17.69. Medpace financial statements analysis is a perfect complement when working with Medpace Holdings Valuation or Volatility modules.
  
This module can also supplement Medpace Holdings' financial leverage analysis and stock options assessment as well as various Medpace Holdings Technical models . Check out the analysis of Medpace Holdings Correlation against competitors.
To learn how to invest in Medpace Stock, please use our How to Invest in Medpace Holdings guide.

Latest Medpace Holdings' Free Cash Flow Per Share Growth Pattern

Below is the plot of the Free Cash Flow Per Share of Medpace Holdings over the last few years. It is the amount of cash a company generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share. Medpace Holdings' Free Cash Flow Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Medpace Holdings' overall financial position and show how it may be relating to other accounts over time.
Free Cash Flow Per Share10 Years Trend
Slightly volatile
   Free Cash Flow Per Share   
       Timeline  

Medpace Free Cash Flow Per Share Regression Statistics

Arithmetic Mean5.16
Geometric Mean3.99
Coefficient Of Variation79.53
Mean Deviation3.26
Median2.44
Standard Deviation4.10
Sample Variance16.83
Range11.6006
R-Value0.86
Mean Square Error4.77
R-Squared0.74
Significance0.000042
Slope0.79
Total Sum of Squares235.63

Medpace Free Cash Flow Per Share History

2024 13.56
2023 12.91
2022 10.84
2021 6.55
2020 6.38
2019 5.13
2018 3.95

About Medpace Holdings Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Medpace Holdings income statement, its balance sheet, and the statement of cash flows. Medpace Holdings investors use historical funamental indicators, such as Medpace Holdings's Free Cash Flow Per Share, to determine how well the company is positioned to perform in the future. Although Medpace Holdings investors may use each financial statement separately, they are all related. The changes in Medpace Holdings's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Medpace Holdings's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Medpace Holdings Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Medpace Holdings. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Free Cash Flow Per Share 12.91  13.56 

Medpace Holdings Investors Sentiment

The influence of Medpace Holdings' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Medpace. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Medpace Holdings' public news can be used to forecast risks associated with an investment in Medpace. The trend in average sentiment can be used to explain how an investor holding Medpace can time the market purely based on public headlines and social activities around Medpace Holdings. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Medpace Holdings' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Medpace Holdings' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Medpace Holdings' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Medpace Holdings.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Medpace Holdings in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Medpace Holdings' short interest history, or implied volatility extrapolated from Medpace Holdings options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Medpace Holdings is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Medpace Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Medpace Holdings Stock. Highlighted below are key reports to facilitate an investment decision about Medpace Holdings Stock:
Check out the analysis of Medpace Holdings Correlation against competitors.
To learn how to invest in Medpace Stock, please use our How to Invest in Medpace Holdings guide.
Note that the Medpace Holdings information on this page should be used as a complementary analysis to other Medpace Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Complementary Tools for Medpace Stock analysis

When running Medpace Holdings' price analysis, check to measure Medpace Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medpace Holdings is operating at the current time. Most of Medpace Holdings' value examination focuses on studying past and present price action to predict the probability of Medpace Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medpace Holdings' price. Additionally, you may evaluate how the addition of Medpace Holdings to your portfolios can decrease your overall portfolio volatility.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Is Medpace Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medpace Holdings. If investors know Medpace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medpace Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.41
Earnings Share
9.81
Revenue Per Share
63.975
Quarterly Revenue Growth
0.177
Return On Assets
0.1389
The market value of Medpace Holdings is measured differently than its book value, which is the value of Medpace that is recorded on the company's balance sheet. Investors also form their own opinion of Medpace Holdings' value that differs from its market value or its book value, called intrinsic value, which is Medpace Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medpace Holdings' market value can be influenced by many factors that don't directly affect Medpace Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medpace Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Medpace Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medpace Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.